Cosmos Health Inc (NASDAQ: COSM)’s stock price has dropped by -6.48 in relation to previous closing price of 0.37. Nevertheless, the company has seen a loss of -0.87% in its stock price over the last five trading days. globenewswire.com reported 2025-04-09 that CHICAGO, April 09, 2025 (GLOBE NEWSWIRE) — Cosmos Health Inc. (“Cosmos Health” or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that its wholly owned subsidiary, Cana Laboratories (“Cana”), has completed the latest upgrades to its manufacturing capabilities and capacity, and has secured a long-term, five-year contract manufacturing agreement with Pharmex S.A. (“Pharmex”) for the annual production of 300,000 bottles of the antiseptic drug AMBITASOL 1L, totaling 1,500,000 units over the duration of the agreement.
Is It Worth Investing in Cosmos Health Inc (NASDAQ: COSM) Right Now?
Moreover, the 36-month beta value for COSM is 4.28. Analysts have varying opinions on the stock, with 0 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for COSM is 16.37M and currently, short sellers hold a 3.85% of that float. On April 15, 2025, COSM’s average trading volume was 446.63K shares.
COSM’s Market Performance
COSM stock saw a decrease of -0.87% in the past week, with a monthly decline of -29.38% and a quarterly a decrease of -44.03%. The volatility ratio for the week is 16.11%, and the volatility levels for the last 30 days are 11.45% for Cosmos Health Inc (COSM). The simple moving average for the past 20 days is -19.66% for COSM’s stock, with a -57.74% simple moving average for the past 200 days.
COSM Trading at -34.47% from the 50-Day Moving Average
After a stumble in the market that brought COSM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -78.35% of loss for the given period.
Volatility was left at 11.45%, however, over the last 30 days, the volatility rate increased by 16.11%, as shares sank -32.14% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -51.69% lower at present.
During the last 5 trading sessions, COSM fell by -0.87%, which changed the moving average for the period of 200-days by -46.98% in comparison to the 20-day moving average, which settled at $0.4260. In addition, Cosmos Health Inc saw -48.88% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at COSM starting from Siokas Grigorios, who purchase 85,714 shares at the price of $0.53 back on Mar 04 ’25. After this action, Siokas Grigorios now owns 4,115,302 shares of Cosmos Health Inc, valued at $45,000 using the latest closing price.
Siokas Grigorios, the Chief Executive Officer of Cosmos Health Inc, purchase 132,572 shares at $0.49 during a trade that took place back on Mar 03 ’25, which means that Siokas Grigorios is holding 4,029,588 shares at $65,000 based on the most recent closing price.
Stock Fundamentals for COSM
Current profitability levels for the company are sitting at:
- -0.36 for the present operating margin
- 0.08 for the gross margin
The net margin for Cosmos Health Inc stands at -0.36. The total capital return value is set at -0.51.
Based on Cosmos Health Inc (COSM), the company’s capital structure generated 0.24 points at debt to capital in total, while cash flow to debt ratio is standing at -0.33. The debt to equity ratio resting at 0.32. The interest coverage ratio of the stock is -19.59.
Currently, EBITDA for the company is -17.06 million with net debt to EBITDA at -0.42. When we switch over and look at the enterprise to sales, we see a ratio of 0.28. The receivables turnover for the company is 3.21for trailing twelve months and the total asset turnover is 0.87. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.44.
Conclusion
To wrap up, the performance of Cosmos Health Inc (COSM) has been bad in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
